Empagliflozin for acute myocardial infarction with increased risk of heart failure = fewer HF hospitalizations, no effect on mortality (EMPACT-MI)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Empagliflozin for Acute Myocardial Infarction With Increased Risk of Heart Failure = Fewer HF Hospitalizations, No Effect On Mortality (EMPACT-MI)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377123/all/Empagliflozin_for_acute_myocardial_infarction_with_increased_risk_of_heart_failure_=_fewer_HF_hospitalizations__no_effect_on_mortality__EMPACT_MI_.
Empagliflozin for acute myocardial infarction with increased risk of heart failure = fewer HF hospitalizations, no effect on mortality (EMPACT-MI). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377123/all/Empagliflozin_for_acute_myocardial_infarction_with_increased_risk_of_heart_failure_=_fewer_HF_hospitalizations__no_effect_on_mortality__EMPACT_MI_. Accessed October 5, 2024.
Empagliflozin for acute myocardial infarction with increased risk of heart failure = fewer HF hospitalizations, no effect on mortality (EMPACT-MI). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377123/all/Empagliflozin_for_acute_myocardial_infarction_with_increased_risk_of_heart_failure_=_fewer_HF_hospitalizations__no_effect_on_mortality__EMPACT_MI_
Empagliflozin for Acute Myocardial Infarction With Increased Risk of Heart Failure = Fewer HF Hospitalizations, No Effect On Mortality (EMPACT-MI) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 October 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377123/all/Empagliflozin_for_acute_myocardial_infarction_with_increased_risk_of_heart_failure_=_fewer_HF_hospitalizations__no_effect_on_mortality__EMPACT_MI_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Empagliflozin for acute myocardial infarction with increased risk of heart failure = fewer HF hospitalizations, no effect on mortality (EMPACT-MI)
ID - 3377123
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377123/all/Empagliflozin_for_acute_myocardial_infarction_with_increased_risk_of_heart_failure_=_fewer_HF_hospitalizations__no_effect_on_mortality__EMPACT_MI_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -